Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

The STING ligand cGAMP potentiates the efficacy of vaccine-induced CD8+ T cells.

Gutjahr A, Papagno L, Nicoli F, Kanuma T, Kuse N, Cabral-Piccin MP, Rochereau N, Gostick E, Lioux T, Perouzel E, Price DA, Takiguchi M, Verrier B, Yamamoto T, Paul S, Appay V.

JCI Insight. 2019 Apr 4;4(7). pii: 125107. doi: 10.1172/jci.insight.125107. eCollection 2019 Apr 4.

2.

New Insights into Lymphocyte Differentiation and Aging from Telomere Length and Telomerase Activity Measurements.

Fali T, Papagno L, Bayard C, Mouloud Y, Boddaert J, Sauce D, Appay V.

J Immunol. 2019 Apr 1;202(7):1962-1969. doi: 10.4049/jimmunol.1801475. Epub 2019 Feb 8.

PMID:
30737273
3.

Naïve CD8+ T-Cells Engage a Versatile Metabolic Program Upon Activation in Humans and Differ Energetically From Memory CD8+ T-Cells.

Nicoli F, Papagno L, Frere JJ, Cabral-Piccin MP, Clave E, Gostick E, Toubert A, Price DA, Caputo A, Appay V.

Front Immunol. 2018 Dec 21;9:2736. doi: 10.3389/fimmu.2018.02736. eCollection 2018.

4.

Elderly human hematopoietic progenitor cells express cellular senescence markers and are more susceptible to pyroptosis.

Fali T, Fabre-Mersseman V, Yamamoto T, Bayard C, Papagno L, Fastenackels S, Zoorab R, Koup RA, Boddaert J, Sauce D, Appay V.

JCI Insight. 2018 Jul 12;3(13). pii: 95319. doi: 10.1172/jci.insight.95319.

5.

Cutting Edge: A Dual TLR2 and TLR7 Ligand Induces Highly Potent Humoral and Cell-Mediated Immune Responses.

Gutjahr A, Papagno L, Nicoli F, Lamoureux A, Vernejoul F, Lioux T, Gostick E, Price DA, Tiraby G, Perouzel E, Appay V, Verrier B, Paul S.

J Immunol. 2017 Jun 1;198(11):4205-4209. doi: 10.4049/jimmunol.1602131. Epub 2017 Apr 21.

6.

Preservation of Lymphopoietic Potential and Virus Suppressive Capacity by CD8+ T Cells in HIV-2-Infected Controllers.

Angin M, Wong G, Papagno L, Versmisse P, David A, Bayard C, Charmeteau-De Muylder B, Besseghir A, Thiébaut R, Boufassa F, Pancino G, Sauce D, Lambotte O, Brun-Vézinet F, Matheron S, Rowland-Jones SL, Cheynier R, Sáez-Cirión A, Appay V; ANRS CO5 IMMUNOVIR-2 Study Group.

J Immunol. 2016 Oct 1;197(7):2787-95. doi: 10.4049/jimmunol.1600693. Epub 2016 Aug 26.

7.

Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial.

Katlama C, Lambert-Niclot S, Assoumou L, Papagno L, Lecardonnel F, Zoorob R, Tambussi G, Clotet B, Youle M, Achenbach CJ, Murphy RL, Calvez V, Costagliola D, Autran B; EraMune-01 study team.

AIDS. 2016 Jan;30(2):221-30. doi: 10.1097/QAD.0000000000000894.

PMID:
26684819
8.

Reduced naïve CD8(+) T-cell priming efficacy in elderly adults.

Briceño O, Lissina A, Wanke K, Afonso G, von Braun A, Ragon K, Miquel T, Gostick E, Papagno L, Stiasny K, Price DA, Mallone R, Sauce D, Karrer U, Appay V.

Aging Cell. 2016 Feb;15(1):14-21. doi: 10.1111/acel.12384. Epub 2015 Oct 15.

9.

Vitamin D supplementation is associated with reduced immune activation levels in HIV-1-infected patients on suppressive antiretroviral therapy.

Fabre-Mersseman V, Tubiana R, Papagno L, Bayard C, Briceno O, Fastenackels S, Dudoit Y, Rostane H, Salmon D, Costagliola D, Caby F, Sauce D, Viard JP, Appay V.

AIDS. 2014 Nov 28;28(18):2677-82. doi: 10.1097/QAD.0000000000000472.

PMID:
25493593
10.

The link between CD8⁺ T-cell antigen-sensitivity and HIV-suppressive capacity depends on HLA restriction, target epitope and viral isolate.

Lissina A, Fastenackels S, Inglesias MC, Ladell K, McLaren JE, Briceño O, Gostick E, Papagno L, Autran B, Sauce D, Price DA, Saez-Cirion A, Appay V.

AIDS. 2014 Feb 20;28(4):477-86. doi: 10.1097/QAD.0000000000000175.

11.

The tyrosine kinase inhibitor Dasatinib blocks in-vitro HIV-1 production by primary CD4+ T cells from HIV-1 infected patients.

Pogliaghi M, Papagno L, Lambert S, Calin R, Calvez V, Katlama C, Autran B.

AIDS. 2014 Jan 14;28(2):278-81. doi: 10.1097/QAD.0000000000000073.

PMID:
24361684
12.

Direct quantification of cell-associated HIV DNA in isolated rectal and blood memory CD4 T cells revealed their similar and low infection levels in long-term treated HIV-infected patients.

Descours B, Lambert-Niclot S, Mory B, Samri A, Charlotte F, Peytavin G, Tubiana R, Papagno L, Bacchus C, Lecardonnel F, Katlama C, Autran B, Marcelin AG, Valantin MA, Carcelain G; DECAMUNE and ORVACS Study Groups.

J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):255-9. doi: 10.1097/QAI.0b013e318282537f.

PMID:
23274932
13.

Exhausted cytotoxic control of Epstein-Barr virus in human lupus.

Larsen M, Sauce D, Deback C, Arnaud L, Mathian A, Miyara M, Boutolleau D, Parizot C, Dorgham K, Papagno L, Appay V, Amoura Z, Gorochov G.

PLoS Pathog. 2011 Oct;7(10):e1002328. doi: 10.1371/journal.ppat.1002328. Epub 2011 Oct 20.

14.

Comprehensive analysis of virus-specific T-cells provides clues for the failure of therapeutic immunization with ALVAC-HIV vaccine.

Papagno L, Alter G, Assoumou L, Murphy RL, Garcia F, Clotet B, Larsen M, Braibant M, Marcelin AG, Costagliola D, Altfeld M, Katlama C, Autran B; ORVACS Study Group.

AIDS. 2011 Jan 2;25(1):27-36. doi: 10.1097/QAD.0b013e328340fe55.

PMID:
21076273
15.

Changes in T-cell subsets in HIV-HCV-coinfected patients during pegylated interferon-alpha2a plus ribavirin treatment.

Massanella M, Tural C, Papagno L, Garcia E, Jou A, Bofill M, Autran B, Clotet B, Blanco J.

Antivir Ther. 2010;15(3):333-42. doi: 10.3851/IMP1531.

PMID:
20516553
16.

Upregulation of interleukin 7 receptor alpha and programmed death 1 marks an epitope-specific CD8+ T-cell response that disappears following primary Epstein-Barr virus infection.

Sauce D, Larsen M, Abbott RJ, Hislop AD, Leese AM, Khan N, Papagno L, Freeman GJ, Rickinson AB.

J Virol. 2009 Sep;83(18):9068-78. doi: 10.1128/JVI.00141-09. Epub 2009 Jul 15.

17.

A step ahead on the HIV collaboratory.

Murphy RL, Autran B, Katlama C, Brucker G, Debre P, Calvez V, Clotet B, Clumeck N, Costagliola D, Deeks SG, Dorrell L, Gatell J, Haase A, Klein M, Lazzarin A, McMichael AJ, Papagno L, Schacker TW, Wain-Hobson S, Walker BD, Youle M.

Science. 2009 Jun 5;324(5932):1264-5. doi: 10.1126/science.324_1264b. No abstract available.

PMID:
19498149
18.

Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity.

Almeida JR, Sauce D, Price DA, Papagno L, Shin SY, Moris A, Larsen M, Pancino G, Douek DC, Autran B, Sáez-Cirión A, Appay V.

Blood. 2009 Jun 18;113(25):6351-60. doi: 10.1182/blood-2009-02-206557. Epub 2009 Apr 23.

19.

Near-edge x-ray absorption fine-structure investigation of graphene.

Pacilé D, Papagno M, Rodríguez AF, Grioni M, Papagno L, Girit CO, Meyer JC, Begtrup GE, Zettl A.

Phys Rev Lett. 2008 Aug 8;101(6):066806. Epub 2008 Aug 8.

PMID:
18764491
20.

Multicentric Castleman disease is associated with polyfunctional effector memory HHV-8-specific CD8+ T cells.

Guihot A, Oksenhendler E, Galicier L, Marcelin AG, Papagno L, Bedin AS, Agbalika F, Dupin N, Cadranel J, Autran B, Carcelain G.

Blood. 2008 Feb 1;111(3):1387-95. Epub 2007 Nov 13.

PMID:
18000163
21.

Cell permeabilization for the assessment of T lymphocyte polyfunctional capacity.

Papagno L, Almeida JR, Nemes E, Autran B, Appay V.

J Immunol Methods. 2007 Dec 1;328(1-2):182-8. Epub 2007 Sep 20.

PMID:
17920073
22.

Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover.

Almeida JR, Price DA, Papagno L, Arkoub ZA, Sauce D, Bornstein E, Asher TE, Samri A, Schnuriger A, Theodorou I, Costagliola D, Rouzioux C, Agut H, Marcelin AG, Douek D, Autran B, Appay V.

J Exp Med. 2007 Oct 1;204(10):2473-85. Epub 2007 Sep 24.

23.

Accelerated immune senescence and HIV-1 infection.

Appay V, Almeida JR, Sauce D, Autran B, Papagno L.

Exp Gerontol. 2007 May;42(5):432-7. Epub 2007 Jan 8. Review.

PMID:
17307327
24.

HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor.

Dong T, Stewart-Jones G, Chen N, Easterbrook P, Xu X, Papagno L, Appay V, Weekes M, Conlon C, Spina C, Little S, Screaton G, van der Merwe A, Richman DD, McMichael AJ, Jones EY, Rowland-Jones SL.

J Exp Med. 2004 Dec 20;200(12):1547-57. Epub 2004 Dec 13.

25.

Parenteral exposure to high HIV viremia leads to virus-specific T cell priming without evidence of infection.

Missale G, Papagno L, Penna A, Pilli M, Zerbini A, Vitali P, Pieroni G, Urbani S, Uggeri J, Pinheiro S, Rowland-Jones S, Ferrari C.

Eur J Immunol. 2004 Nov;34(11):3208-15.

26.

Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection.

Papagno L, Spina CA, Marchant A, Salio M, Rufer N, Little S, Dong T, Chesney G, Waters A, Easterbrook P, Dunbar PR, Shepherd D, Cerundolo V, Emery V, Griffiths P, Conlon C, McMichael AJ, Richman DD, Rowland-Jones SL, Appay V.

PLoS Biol. 2004 Feb;2(2):E20. Epub 2004 Feb 17. Review.

27.

Comparison between HIV- and CMV-specific T cell responses in long-term HIV infected donors.

Papagno L, Appay V, Sutton J, Rostron T, Gillespie GM, Ogg GS, King A, Makadzanhge AT, Waters A, Balotta C, Vyakarnam A, Easterbrook PJ, Rowland-Jones SL.

Clin Exp Immunol. 2002 Dec;130(3):509-17.

28.

Characterization of CD4(+) CTLs ex vivo.

Appay V, Zaunders JJ, Papagno L, Sutton J, Jaramillo A, Waters A, Easterbrook P, Grey P, Smith D, McMichael AJ, Cooper DA, Rowland-Jones SL, Kelleher AD.

J Immunol. 2002 Jun 1;168(11):5954-8.

29.

Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.

Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, Papagno L, Ogg GS, King A, Lechner F, Spina CA, Little S, Havlir DV, Richman DD, Gruener N, Pape G, Waters A, Easterbrook P, Salio M, Cerundolo V, McMichael AJ, Rowland-Jones SL.

Nat Med. 2002 Apr;8(4):379-85.

PMID:
11927944
30.

Dynamics of T cell responses in HIV infection.

Appay V, Papagno L, Spina CA, Hansasuta P, King A, Jones L, Ogg GS, Little S, McMichael AJ, Richman DD, Rowland-Jones SL.

J Immunol. 2002 Apr 1;168(7):3660-6. Erratum in: J Immunol 2002 Jul 1;169(1):607.

31.

Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid.

Tambussi G, Gori A, Capiluppi B, Balotta C, Papagno L, Morandini B, Di Pietro M, Ciuffreda D, Saracco A, Lazzarin A.

Clin Infect Dis. 2000 Jun;30(6):962-5.

PMID:
10880317
32.

Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals.

Balotta C, Berlusconi A, Pan A, Violin M, Riva C, Colombo MC, Gori A, Papagno L, Corvasce S, Mazzucchelli R, Facchi G, Velleca R, Saporetti G, Galli M, Rusconi S, Moroni M.

Antivir Ther. 2000 Mar;5(1):7-14.

33.

Identification of two distinct subsets of long-term nonprogressors with divergent viral activity by stromal-derived factor 1 chemokine gene polymorphism analysis.

Balotta C, Bagnarelli P, Corvasce S, Mazzucchelli R, Colombo MC, Papagno L, Santambrogio S, Ridolfo AL, Violin M, Berlusconi A, Velleca R, Facchi G, Moroni M, Clementi M, Galli M.

J Infect Dis. 1999 Aug;180(2):285-9.

34.

Umbilical cord clamping. An analysis of a usual neonatological conduct.

Papagno L.

Acta Physiol Pharmacol Ther Latinoam. 1998;48(4):224-7.

PMID:
9914812
35.

Early increase in cell-associated HIV-1 DNA in patients on highly active antiretroviral therapy.

Galli M, Balotta C, Meroni L, Colombo MC, Papagno L, Bagnarelli P, Testa L, Varchetta S, Colombo L, Moroni M, d'Arminio Monforte A, Clerici M, Clementi M.

AIDS. 1998 Dec 24;12(18):2500-2. No abstract available.

PMID:
9875591
36.

Patterns of in vitro anti-human immunodeficiency virus type 1 antibody production in long-term nonprogressors.

Rusconi S, Berlusconi A, Papagno L, Colombo MC, De Maddalena C, Riva A, Bagnarelli P, Balotta C, Galli M.

Clin Immunol Immunopathol. 1997 Dec;85(3):320-3.

37.

Plasma viremia and virus phenotype are correlates of disease progression in vertically human immunodeficiency virus type 1-infected children.

Balotta C, Colombo MC, Colucci G, Viganò A, Riva C, Papagno L, Violin M, Crupi L, Bricalli D, Salvaggio A, Moroni M, Principi N, Galli M.

Pediatr Infect Dis J. 1997 Feb;16(2):205-11.

PMID:
9041602
38.

Chemokine production in HIV-seropositive long-term asymptomatic individuals.

Clerici M, Balotta C, Trabattoni D, Papagno L, Ruzzante S, Rusconi S, Fusi ML, Colombo MC, Galli M.

AIDS. 1996 Oct;10(12):1432-3. No abstract available.

PMID:
8902076
39.

HIV type 1 phenotype correlates with the stage of infection in vertically infected children.

Balotta C, Viganò A, Riva C, Colombo MC, Salvaggio A, de Pasquale MP, Crupi L, Papagno L, Galli M, Moroni M, Principi N.

AIDS Res Hum Retroviruses. 1996 Sep 1;12(13):1247-53.

PMID:
8870846
40.

Surface Holography by Angle-Resolved Electron-Energy-Loss Spectroscopy.

Caputi LS, Comite O, Amoddeo A, Chiarello G, Scalese S, Colavita E, Papagno L.

Phys Rev Lett. 1996 Aug 5;77(6):1059-1062. No abstract available.

PMID:
10062980
41.

Human immunodeficiency virus (HIV) phenotype and interleukin-2/ interleukin-10 ratio are associated markers of protection and progression in HIV infection.

Clerici M, Balotta C, Salvaggio A, Riva C, Trabattoni D, Papagno L, Berlusconi A, Rusconi S, Villa ML, Moroni M, Galli M.

Blood. 1996 Jul 15;88(2):574-9.

PMID:
8695805
42.

K-induced surface vibrations on Ni(111).

Chiarello G, Cupolillo A, Amoddeo A, Caputi LS, Papagno L, Colavita E.

Phys Rev B Condens Matter. 1995 Aug 15;52(7):4752-4755. No abstract available.

PMID:
9981651
43.

Angle-resolved photoemission investigation of the (2 x 1) carbidic carbon on Ni(110).

Papagno L, Conti M, Caputi LS, Anderson J, Lapeyre GJ.

Phys Rev B Condens Matter. 1991 Jul 15;44(4):1904-1909. No abstract available.

PMID:
9999730
44.

Structure of the (2 x 1) carbidic carbon on Ni(110).

Caputi LS, Amoddeo A, Tucci R, Papagno L.

Phys Rev B Condens Matter. 1991 Jul 15;44(3):1357-1359. No abstract available.

PMID:
9999653
45.

Comparative study of water adsorption on Ge(100)-(2 x 1) and GexSi1-x(100)-(2 x 1) by high-resolution electron-energy-loss spectroscopy.

Papagno L, Caputi LS, Anderson J, Lapeyre GJ.

Phys Rev B Condens Matter. 1989 Oct 15;40(12):8443-8445. No abstract available.

PMID:
9991308
46.

Hydrogen adsorption on Ge(100) studied by high-resolution energy-loss spectroscopy.

Papagno L, Shen XY, Anderson J, Schirripa Spagnolo G, Lapeyre GJ.

Phys Rev B Condens Matter. 1986 Nov 15;34(10):7188-7191. No abstract available.

PMID:
9939374
47.

Secondary-electron emission and electron-energy-loss results on graphite single crystals.

Caputi LS, Chiarello G, Santaniello A, Colavita E, Papagno L.

Phys Rev B Condens Matter. 1986 Nov 1;34(9):6080-6084. No abstract available.

PMID:
9940480
48.

Direct picture of the local electronic structure during the Si(111)7 x 7-Al Schottky-barrier formation process.

Kelly MK, Margaritondo G, Papagno L, Lapeyre GJ.

Phys Rev B Condens Matter. 1986 Oct 15;34(8):6011-6013. No abstract available.

PMID:
9940466
49.

High-resolution electron energy loss as a probe of the Si-Al Schottky-barrier formation process.

Kelly MK, Colavita E, Margaritondo G, Anderson J, Papagno L, Frankel DJ, Lapeyre GJ.

Phys Rev B Condens Matter. 1985 Aug 15;32(4):2693-2695. No abstract available.

PMID:
9937365

Supplemental Content

Loading ...
Support Center